- Ticker
- ADMP
- Price
- 0.12
- Stock movement up
- +0.02 (14.61%)
- Company name
- Adamis Pharma
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Drug Manufacturers-Specialty & Generic
- Market cap
- 18.00M
- Ent value
- 24.87M
- Price/Sales
- 11.68
- Price/Book
- 6.33
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -81.25%
- 3 year return
- -29.75%
- 5 year return
- -48.84%
- 10 year return
- -35.76%
Last updated: 2023-03-22
Adamis Pharmaceuticals Corporation (NASDAQ:NASDAQ:ADMP) Q4 2022 Results Conference Call March 16, 2023 5:00 PM ETCompany ParticipantsRobert Uhl - MD, ICR WestwickeDavid Marguglio - CEODavid...
March 17, 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Adamis Pharmaceuticals Corporation (ADMP) stock at Seeking Alpha.
March 16, 2023
iO Charts is a Seeking Alpha partner
DIVIDENDS
ADMP does not pay dividends or no data was received
Get the latest news and real-time alerts from Adamis Pharmaceuticals Corporation (ADMP) stock at Seeking Alpha.
March 14, 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Adamis Pharmaceuticals Corporation (ADMP) stock at Seeking Alpha.
February 23, 2023
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 11.68 |
| Price to Book | 6.33 |
| EV to Sales | 16.14 |
Adamis Pharmaceuticals Corporation (NASDAQ:NASDAQ:ADMP) Q3 2022 Earnings Conference Call November 14, 2022 5:00 PM ETCompany ParticipantsRobert Uhl - Westwicke PartnersDavid Marguglio -...
November 15, 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Adamis Pharmaceuticals Corporation (ADMP) stock at Seeking Alpha.
November 14, 2022
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 149.98M |
| EPS (TTM) | -0.21 |
| FCF per share (TTM) | -0.21 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 1.54M |
| Gross profit (TTM) | -4.25M |
| Operating income (TTM) | -28.63M |
| Net income (TTM) | -31.92M |
| EPS (TTM) | -0.21 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | -276.18% |
| Operating margin (TTM) | -1858.60% |
| Profit margin (TTM) | -2072.23% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 2.42M |
| Net receivables | 1.55M |
| Total current assets | 10.09M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 12.14M |
| Accounts payable | 5.30M |
| Short/Current long term debt | 432.02K |
| Total current liabilities | 8.87M |
| Total liabilities | 9.29M |
| Shareholder's equity | 2.85M |
| Net tangible assets | 2.85M |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -31.05M |
| Capital expenditures (TTM) | 816.10K |
| Free cash flow (TTM) | -31.84M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -1121.97% |
| Return on Assets | -263.03% |
| Return on Invested Capital | -993.24% |
| Cash Return on Invested Capital | -990.63% |
Get the latest news and real-time alerts from Adamis Pharmaceuticals Corporation (ADMP) stock at Seeking Alpha.
October 3, 2022
iO Charts is a Seeking Alpha partner
Adamis has a long track record of fumbles and failures. I'm finally ready to put ADMP on my “Wall of Shame” and ultimately mothball the position. Read more here.
September 30, 2022
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.10 |
| Daily high | 0.13 |
| Daily low | 0.10 |
| Daily Volume | 1.51M |
| All-time high | 1835.63 |
| 1y analyst estimate | 0.42 |
| Beta | 1.29 |
| EPS (TTM) | -0.21 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 15 May 2023 |
Downside potential
Loading...
Downside potential data
| ADMP | S&P500 | |
| Current price drop from All-time high | -99.99% | -17.92% |
| Highest price drop | -99.99% | -56.47% |
| Date of highest drop | 20 Mar 2023 | 9 Mar 2009 |
| Avg drop from high | -80.35% | -11.51% |
| Avg time to new high | 253 days | 13 days |
| Max time to new high | 5749 days | 1805 days |
Get the latest news and real-time alerts from Adamis Pharmaceuticals Corporation (ADMP) stock at Seeking Alpha.
September 21, 2022
iO Charts is a Seeking Alpha partner
Adamis Pharmaceuticals Corporation (NASDAQ:NASDAQ:ADMP) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ETCompany ParticipantsRobert Uhl - Managing Director, ICR WestwickeDavid J.
August 11, 2022
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
18.00M
Marketcap category
Small-cap
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products for the treatment of asthma; and naloxone injection for the treatment of opioid overdose. It also offers APC400, a tempol gel use of reducing radiation dermatitis in patients undergoing treatment for cancer; and APC410 for the treatment of respiratory diseases, including asthma, respiratory syncytial virus, influenza, and COVID-19. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, and injectables; and veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation was founded in 2006 and is headquartered in San Diego, California.
Employees
15
Investor relations
-
SEC filings
CEO
Dennis J. Carlo
Country
USA
City
San Diego
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
Get the latest news and real-time alerts from Adamis Pharmaceuticals Corporation (ADMP) stock at Seeking Alpha.
August 10, 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Adamis Pharmaceuticals Corporation (ADMP) stock at Seeking Alpha.
July 29, 2022
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
Get the latest news and real-time alerts from Adamis Pharmaceuticals Corporation (ADMP) stock at Seeking Alpha.
July 21, 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Adamis Pharmaceuticals Corporation (ADMP) stock at Seeking Alpha.
May 18, 2022
iO Charts is a Seeking Alpha partner
COMPANY NEWS
All newsPress releases
Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Q4 2022 Earnings Call Transcript March 17, 2023 Operator: Greetings, and welcome to the Adamis Pharmaceuticals Full Year 2022 Financial Results Confere...
March 20, 2023
Q4 2022 Adamis Pharmaceuticals Corp Earnings Call
March 17, 2023
Management to host webcast/conference call today at 2 p.m. PT / 5 p.m. ETSAN DIEGO, March 16, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company fo...
March 16, 2023
SAN DIEGO, March 14, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company primarily focused on developing and commercializing produc...
March 14, 2023
SAN DIEGO, March 14, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company primarily focused on developing and commercializing produc...
March 14, 2023
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) and DMK Pharmaceuticals Corp entered into an Agreement and Plan of Merger and Reorganization. DMK Pharmaceuticals is a privately held, clinical-stage ...
February 28, 2023
Combined company will have commercial products and a library of development candidates, two of which are clinical stageWill be under the leadership of DMK CEO, Dr. Ebrahim (Eboo) Versi MD, PhDLead dev...
February 27, 2023
SAN DIEGO, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company primarily focused on developing and commercializing product...
February 22, 2023
Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Q3 2022 Earnings Call Transcript November 14, 2022 Operator: Good afternoon, ladies and gentlemen, and welcome to the Adamis Pharmaceuticals’ Third Qua...
December 29, 2022
Management to host webcast/conference call today at 2:00 p.m. PT / 5:00 p.m. ETSAN DIEGO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopha...
November 14, 2022
Next page
Get the latest news and real-time alerts from Adamis Pharmaceuticals Corporation (ADMP) stock at Seeking Alpha.
May 17, 2022
iO Charts is a Seeking Alpha partner
Adamis Pharmaceuticals Corporation (NASDAQ:NASDAQ:ADMP) Q1 2022 Earnings Conference Call May 16, 2022 5:00 PM ETCorporate ParticipantsRobert Uhl - ICR WestwickeDennis Carlo - President and...
May 17, 2022
iO Charts is a Seeking Alpha partner